Drug-amino acid co-amorphous systems have become increasingly well-investigated
systems to improve dissolution rate of poorly water-soluble drugs. In this study, dipeptides …

Co-amorphous drug delivery systems are attracting increasing attention in the
pharmaceutical field, due to their promising potential to improve the solubility and …

The novel coronavirus disease, COVID‐19, has grown into a global pandemic and a major
public health threat since its breakout in December 2019. To date, no specific therapeutic …

SARS-CoV-2 is a novel coronavirus that was isolated and identified for the first time in
Wuhan, China in 2019. Nowadays, it is a worldwide danger and the WHO named it a …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified in
China as the etiologic agent of the recent COVID-19 pandemic outbreak. Due to its high …

Co-amorphous drug delivery systems based on amino acids as co-formers have shown
promising potential to improve the solubility and bioavailability of poorly water-soluble …

Co-amorphous solid dispersion (C-ASD) systems have attracted great attention to improve
the solubility of poorly soluble drugs, but the selection of an appropriate stabilizer to stabilize …

Amorphization is one of the most effective pharmaceutical approaches to enhance the
dissolution and oral bioavailability of poorly water-soluble drugs. In recent years, amorphous …

Co-amorphous systems comprising low-molecular weight drugs and co-formers constitute
an interesting approach to optimize pharmaceutical performance of drugs with low aqueous …

Co-amorphization has recently been shown to be a promising approach for stabilizing
amorphous drugs and improving the dissolution rate of poorly water-soluble drugs. In this …